A recent study by the Comprehensive Cancer Center and Tobacco Research Center at Ohio State University has revealed that nicotine pouches, a product claimed to be a substitute for tobacco leaves, are not effective in alleviating nicotine addiction among smokers.
This study has been published in the medical journal "Addiction." The study collected data from 30 active adult smokers from the Appalachian community in Ohio. It observed the changes in nicotine levels in their blood during three different phases: smoking, and using nicotine pouches containing either 3mg or 6mg of nicotine.
A research team has found that current smokers have higher nicotine levels in their bloodstream and experience more noticeable relief from smoking addiction symptoms, compared to those using low-dose and high-dose nicotine pouches.
According to lead author Keller Hamilton, the peak level of nicotine in the bloodstream can be detected approximately five minutes after smoking.
For nicotine pouches, like other smokeless tobacco products, it is a gradual process that typically takes 30 minutes to an hour to achieve optimal effects, and the decline in nicotine levels is also gradual, with nicotine pouches seeing a slower decline in nicotine levels.
She stated that, for individuals already addicted to nicotine, smoking is more enticing for satisfying immediate cravings than using nicotine pouches.
Keller says, "Nicotine addiction is a very real problem for many people, with most current smokers expressing a desire to quit but often failing due to the difficulty of quitting and maintaining it in the long term.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
